LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Granata, Mariagrazia"
  2. AU="Atek, Hakim"
  3. AU="Liu, Tingwen"
  4. AU="Cable, Jo"
  5. AU="Orsetta Zuffardi"
  6. AU="Brunner, David"
  7. AU="Monserrat, Nuria"
  8. AU="Dufresne, Philippe J"
  9. AU="Dickey, Erin M"
  10. AU="Alessia Nava"
  11. AU="Yamoah, Peter"
  12. AU="Solit, David"
  13. AU="Raymond, Benjamin"
  14. AU="Maddi, Abhiram"
  15. AU="Rodríguez, Johanna G"
  16. AU="Frans, J"
  17. AU="Elisa Palazzari"

Suchergebnis

Treffer 1 - 10 von insgesamt 12

Suchoptionen

  1. Artikel ; Online: S100A7 in Psoriasis: Immunodetection and Activation by CRISPR technology.

    Granata, Mariagrazia / Skarmoutsou, Evangelia / Mazzarino, Maria Clorinda / D'Amico, Fabio

    Methods in molecular biology (Clifton, N.J.)

    2019  Band 1929, Seite(n) 729–738

    Abstract: Psoriasis, an inflammatory autoimmune skin disease, is the result of a chronic interaction between hyperproliferative keratinocytes and infiltrating activated immune cells. The mechanisms underlying psoriasis pathogenesis remain largely unknown, although ...

    Abstract Psoriasis, an inflammatory autoimmune skin disease, is the result of a chronic interaction between hyperproliferative keratinocytes and infiltrating activated immune cells. The mechanisms underlying psoriasis pathogenesis remain largely unknown, although a combination of genetic and environmental factors plays an important role in its development. S100A7 is overexpressed in psoriasis, and there is growing evidence that S100A7 may be involved in the pathogenesis of psoriasis. Since the mechanisms underlying S100A7 regulation and function remain elusive, a better understanding of these mechanisms may be useful to uncover additional treatment approaches for psoriasis. Immunohistology provides invaluable tools for a better understanding of the pathogenetic mechanisms of psoriasis. Here, we describe basic methods for immunofluorescence and immunohistochemistry analysis of S100A7 expression in psoriatic patients as well as in S100A7 CRISPR-activated human keratinocyte cell line.
    Mesh-Begriff(e) COP9 Signalosome Complex/metabolism ; CRISPR-Cas Systems ; Cell Line ; Fluorescent Antibody Technique ; Humans ; Intracellular Signaling Peptides and Proteins/metabolism ; Keratinocytes/cytology ; Keratinocytes/metabolism ; Peptide Hydrolases/metabolism ; Psoriasis/genetics ; Psoriasis/metabolism ; S100 Calcium Binding Protein A7/genetics ; S100 Calcium Binding Protein A7/metabolism ; Transcriptional Activation ; Up-Regulation
    Chemische Substanzen Intracellular Signaling Peptides and Proteins ; S100 Calcium Binding Protein A7 ; S100A7 protein, human ; Peptide Hydrolases (EC 3.4.-) ; COPS5 protein, human (EC 3.4.-.-) ; COP9 Signalosome Complex (EC 3.4.19.12)
    Sprache Englisch
    Erscheinungsdatum 2019-02-01
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-4939-9030-6_45
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte.

    Granata, Mariagrazia / Skarmoutsou, Evangelia / Mazzarino, Maria Clorinda / Libra, Massimo / D'Amico, Fabio

    Methods in molecular biology (Clifton, N.J.)

    2019  Band 2109, Seite(n) 67–74

    Abstract: The application of immunohistological methods provides an invaluable contribution in revealing the protein colocalization, which may reflect the occurrence of molecular interaction processes.This chapter describes comprehensive protocols for detection of ...

    Abstract The application of immunohistological methods provides an invaluable contribution in revealing the protein colocalization, which may reflect the occurrence of molecular interaction processes.This chapter describes comprehensive protocols for detection of S100A7/JAB1 colocalization by immunohistochemistry in archival formalin-fixed and paraffin-embedded skin biopsies from healthy and psoriatic subjects. In addition, we provide a protocol for immunocytochemical detection of S100A7/JAB1 colocalization in S100A7 CRISPR-activated human keratinocyte cell line.
    Mesh-Begriff(e) Biopsy ; COP9 Signalosome Complex/metabolism ; CRISPR-Cas Systems ; Case-Control Studies ; Cell Line ; Humans ; Immunohistochemistry ; Intracellular Signaling Peptides and Proteins/metabolism ; Keratinocytes/metabolism ; Peptide Hydrolases/metabolism ; Psoriasis/metabolism ; Psoriasis/pathology ; S100 Calcium Binding Protein A7/genetics ; S100 Calcium Binding Protein A7/metabolism ; Tissue Embedding ; Tissue Fixation
    Chemische Substanzen Intracellular Signaling Peptides and Proteins ; S100 Calcium Binding Protein A7 ; S100A7 protein, human ; Peptide Hydrolases (EC 3.4.-) ; COPS5 protein, human (EC 3.4.-.-) ; COP9 Signalosome Complex (EC 3.4.19.12)
    Sprache Englisch
    Erscheinungsdatum 2019-08-09
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/7651_2019_251
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: S100A7, Jab1, and p27

    Granata, Mariagrazia / Skarmoutsou, Evangelia / Gangemi, Pietro / Mazzarino, Maria C / D'Amico, Fabio

    Journal of cellular biochemistry

    2018  Band 120, Heft 3, Seite(n) 3384–3392

    Abstract: Psoriasis, a chronic immune-mediated inflammatory skin disease, is characterized by dysregulated keratinocyte proliferation. The EF-hand calcium binding protein S100A7 has been found to be overexpressed in psoriatic keratinocytes. It is know that S100A7 ... ...

    Abstract Psoriasis, a chronic immune-mediated inflammatory skin disease, is characterized by dysregulated keratinocyte proliferation. The EF-hand calcium binding protein S100A7 has been found to be overexpressed in psoriatic keratinocytes. It is know that S100A7 may interact with Jab1, a cofactor that stabilizes c-Jun. Jab1 is known to downregulate the expression of the cell cycle inhibitor p27
    Mesh-Begriff(e) COP9 Signalosome Complex/genetics ; COP9 Signalosome Complex/metabolism ; CRISPR-Cas Systems ; Case-Control Studies ; Cell Nucleus/metabolism ; Cyclin-Dependent Kinase Inhibitor p27/genetics ; Cyclin-Dependent Kinase Inhibitor p27/metabolism ; Cytoplasm/metabolism ; Humans ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/metabolism ; Keratinocytes/cytology ; Keratinocytes/metabolism ; Peptide Hydrolases/genetics ; Peptide Hydrolases/metabolism ; Psoriasis/genetics ; Psoriasis/metabolism ; Psoriasis/pathology ; S100 Calcium Binding Protein A7/antagonists & inhibitors ; S100 Calcium Binding Protein A7/genetics ; S100 Calcium Binding Protein A7/metabolism
    Chemische Substanzen CDKN1B protein, human ; Intracellular Signaling Peptides and Proteins ; S100 Calcium Binding Protein A7 ; S100A7 protein, human ; Cyclin-Dependent Kinase Inhibitor p27 (147604-94-2) ; Peptide Hydrolases (EC 3.4.-) ; COPS5 protein, human (EC 3.4.-.-) ; COP9 Signalosome Complex (EC 3.4.19.12)
    Sprache Englisch
    Erscheinungsdatum 2018-09-11
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 392402-6
    ISSN 1097-4644 ; 0730-2312
    ISSN (online) 1097-4644
    ISSN 0730-2312
    DOI 10.1002/jcb.27609
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: I microRNA nelle principali patologie renali: una nuova frontiera per il nefrologo.

    Granata, Mariagrazia / Malatino, Lorenzo / Zanoli, Luca / Fatuzzo, Pasquale / Granata, Antonio

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

    2016  Band 33, Heft 4

    Abstract: miRNAs are short non-coding RNAs that play a key role in the homeostasis and in the onset of many diseases. Different studies on nephropathies have identified miRNAs that are differentially expressed in nephropathic subjects compared to healthy controls. ...

    Titelübersetzung miRNAs in main renal diseases: a new frontier for the nephrologist.
    Abstract miRNAs are short non-coding RNAs that play a key role in the homeostasis and in the onset of many diseases. Different studies on nephropathies have identified miRNAs that are differentially expressed in nephropathic subjects compared to healthy controls. An important goal of these studies is to give the nephrologist the possibility to diagnose different nephropathies based on liquid biopsies that are less invasive for the patient than solid ones. The present review focalizes on the function of miRNAs in human physiology and renal diseases and analyzes the potential role that, in the near future, they may have in the diagnosis and treatment of acute and chronic kidney diseases.
    Mesh-Begriff(e) Humans ; Kidney Diseases/diagnosis ; Kidney Diseases/genetics ; Kidney Diseases/therapy ; MicroRNAs/physiology ; Nephrology
    Chemische Substanzen MicroRNAs
    Sprache Italienisch
    Erscheinungsdatum 2016-07
    Erscheinungsland Italy
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1237110-5
    ISSN 1724-5990 ; 0393-5590
    ISSN (online) 1724-5990
    ISSN 0393-5590
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip.

    Granata, Mariagrazia / Skarmoutsou, Evangelia / Trovato, Chiara / Rossi, Giulio A / Mazzarino, Maria Clorinda / D'Amico, Fabio

    Pathobiology : journal of immunopathology, molecular and cellular biology

    2017  Band 84, Heft 2, Seite(n) 71–79

    Abstract: Obesity, type 1 diabetes, and psoriasis are wide-ranging health problems. Genetics, epigenetics, and environmental factors together with immune disturbances are involved in these diseases. The white adipose tissue is an active endocrine organ, secreting ... ...

    Abstract Obesity, type 1 diabetes, and psoriasis are wide-ranging health problems. Genetics, epigenetics, and environmental factors together with immune disturbances are involved in these diseases. The white adipose tissue is an active endocrine organ, secreting a wide variety of soluble mediators called adipokines that have a central role in the relationship between adipose tissue and immune system. Inflammatory cytokines, including the IL-23/IL-17 and IL-18 axes, and microRNAs are involved in many processes, including immunity and inflammation, thus having a major role in the onset of these three diseases. In this review, we present an overview of the roles of adipokines, cytokines, and microRNAs in the pathogenesis and the progression of these three diseases.
    Mesh-Begriff(e) Adipokines/immunology ; Adipose Tissue, White/immunology ; Autoimmune Diseases/immunology ; Cytokines/immunology ; Diabetes Mellitus, Type 1/immunology ; Humans ; MicroRNAs/immunology ; Obesity/immunology ; Psoriasis/immunology
    Chemische Substanzen Adipokines ; Cytokines ; MicroRNAs
    Sprache Englisch
    Erscheinungsdatum 2017
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1022703-9
    ISSN 1423-0291 ; 1015-2008
    ISSN (online) 1423-0291
    ISSN 1015-2008
    DOI 10.1159/000447777
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: S100A7: A rAMPing up AMP molecule in psoriasis.

    D'Amico, Fabio / Skarmoutsou, Evangelia / Granata, Mariagrazia / Trovato, Chiara / Rossi, Giulio Antonino / Mazzarino, Maria Clorinda

    Cytokine & growth factor reviews

    2016  Band 32, Seite(n) 97–104

    Abstract: S100A7 (psoriasin), an EF-hand type calcium binding protein localized in epithelial cells, regulates cell proliferation and differentiation. An S100A7 overexpression may occur in response to inflammatory stimuli, such in psoriasis, a chronic inflammatory ...

    Abstract S100A7 (psoriasin), an EF-hand type calcium binding protein localized in epithelial cells, regulates cell proliferation and differentiation. An S100A7 overexpression may occur in response to inflammatory stimuli, such in psoriasis, a chronic inflammatory autoimmune-mediated skin disease. Increasing evidence suggests that S100A7 plays critical roles in amplifying the inflammatory process in psoriatic skin, perpetuating the disease phenotype. This review will discuss the interactions between S100A7 and cytokines in psoriatic skin. Furthermore, we will focus our discussion on regulation and functions of S100A7 in psoriasis. Finally, we will discuss the possible use of S100A7 as therapeutic target in psoriasis.
    Mesh-Begriff(e) Animals ; Antimicrobial Cationic Peptides/immunology ; Cytokines/immunology ; Humans ; Psoriasis/immunology ; S100 Calcium Binding Protein A7/immunology
    Chemische Substanzen Antimicrobial Cationic Peptides ; Cytokines ; S100 Calcium Binding Protein A7
    Sprache Englisch
    Erscheinungsdatum 2016-01-25
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1330534-7
    ISSN 1879-0305 ; 1359-6101
    ISSN (online) 1879-0305
    ISSN 1359-6101
    DOI 10.1016/j.cytogfr.2016.01.002
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Quali test genetici nelle malattie renali.

    Granata, Mariagrazia / Canto, Carolina / Mazzarino, Maria Clorinda / Fatuzzo, Pasquale / Granata, Antonio

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

    2015  Band 32, Heft 5

    Abstract: Clinical genetics plays a central role in the diagnostic practice, mainly due to both the hereditary and non-hereditary genetic component, which characterizes most of the diseases. This branch of medicine has been characterized by a rapid technological ... ...

    Titelübersetzung Which genetic testing in renal disease.
    Abstract Clinical genetics plays a central role in the diagnostic practice, mainly due to both the hereditary and non-hereditary genetic component, which characterizes most of the diseases. This branch of medicine has been characterized by a rapid technological growth since 2003, when the entire human genome was sequenced. We need to consider the reduction in terms of both time and costs that the gene sequencing has gone through. Before, 13 years and about three billion dollars were needed, now it takes only a few weeks and about ten thousand dollars to sequence the entire human genome. The applicability of clinical genetics in nephrology is due to the fact that many kidney diseases are characterized by genetic mutations (e.g., von-Hippel Lindau syndrome, MYH9 related disorders, Fabry's syndrome, Liddle's and Bartter's Syndrome, and others). Clinical genetics plays, therefore, a crucial role since many of these diseases are often not properly diagnosed. In this review, we examine the new technologies that are available to the nephrologist for the molecular diagnosis of renal diseases.
    Mesh-Begriff(e) Chromosome Mapping ; Genetic Testing ; Genomics ; Humans ; Kidney Diseases/diagnosis ; Kidney Diseases/genetics ; Polymerase Chain Reaction
    Sprache Italienisch
    Erscheinungsdatum 2015-09
    Erscheinungsland Italy
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1237110-5
    ISSN 1724-5990 ; 0393-5590
    ISSN (online) 1724-5990
    ISSN 0393-5590
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population.

    D'Amico, Fabio / Fiorito, Giovanni / Skarmoutsou, Evangelia / Granata, Mariagrazia / Rossi, Giulio A / Trovato, Chiara / Bellocchi, Chiara / Marchini, Maurizio / Beretta, Lorenzo / Mazzarino, Maria Clorinda

    Immunobiology

    2018  Band 223, Heft 1, Seite(n) 112–117

    Abstract: Systemic sclerosis (SSc), an autoimmune disorder, is characterized by vasculopathy, inflammation, progressive perivascular and interstitial fibrosis. Its pathogenesis is largely unknown, however strong evidences suggest that genetic predisposition may ... ...

    Abstract Systemic sclerosis (SSc), an autoimmune disorder, is characterized by vasculopathy, inflammation, progressive perivascular and interstitial fibrosis. Its pathogenesis is largely unknown, however strong evidences suggest that genetic predisposition may contribute to SSc development. Several gene polymorphisms involved in regulatory T cell function have been identified in many autoimmune diseases, including SSc. Moreover, dysregulation of co-stimulatory and/or co-inhibitory signals, including ICOS signalling, can lead to autoimmunity. The aim of the present study was to investigate the association of the FOXP3 rs2294020, ICOS rs6726035 and ICOSL rs378299 SNPs with both the susceptibility and the progression to SSc in an Italian case-series of patients. SNP genotyping results were successfully obtained from a total of 350 subjects including 166 individuals with SSc and 184 healthy controls. Although analysis tests did not show any significant associations between the SNPs under study and susceptibility to SSc, the occurrence of FOXP3 rs2294020 in female patients was associated with decreased time to progression from early to definite SSc (allelic model: HR=1.43; CI=1.03-1.99; p=0.03; dominant model: HR=1.54; CI=1.04-2.28; p=0.03). The inclusion of presence of ACA autoantibodies in the model did not significantly change the estimates. No conclusions can be drawn for the susceptibility to the disease or the time to progression in men due to the low statistical power. This study provides evidence of the association of rs2294020 with SSc evolution in female patients, modulating the time of progression from the diagnosis of early SSc to the diagnosis of definite SSc, while no effect on SSc susceptibility per se was found. rs2294020 may be considered a disease-modifying gene-variant rather than a disease-susceptibility SNP in SSc.
    Mesh-Begriff(e) Case-Control Studies ; Disease Progression ; Female ; Forkhead Transcription Factors/genetics ; Gene Frequency ; Genetic Association Studies ; Genetic Predisposition to Disease ; Genotype ; Humans ; Inducible T-Cell Co-Stimulator Ligand/genetics ; Inducible T-Cell Co-Stimulator Protein/genetics ; Italy ; Middle Aged ; Polymorphism, Single Nucleotide ; Scleroderma, Systemic/genetics
    Chemische Substanzen FOXP3 protein, human ; Forkhead Transcription Factors ; ICOS protein, human ; ICOSLG protein, human ; Inducible T-Cell Co-Stimulator Ligand ; Inducible T-Cell Co-Stimulator Protein
    Sprache Englisch
    Erscheinungsdatum 2018
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 563292-4
    ISSN 1878-3279 ; 0171-2985
    ISSN (online) 1878-3279
    ISSN 0171-2985
    DOI 10.1016/j.imbio.2017.10.004
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin.

    D'Amico, Fabio / Trovato, Chiara / Skarmoutsou, Evangelia / Rossi, Giulio A / Granata, Mariagrazia / Longo, Valentina / Gangemi, Pietro / Pettinato, Maurizio / Mazzarino, Maria Clorinda

    Journal of dermatological science

    2015  Band 80, Heft 1, Seite(n) 38–44

    Abstract: Background: Psoriasis is a chronic inflammatory skin disease. It is characterized by immune cell activation and altered epidermal differentiation. S100A7 (psoriasin) is overexpressed in psoriasis, suggesting a determinant role of this protein in ... ...

    Abstract Background: Psoriasis is a chronic inflammatory skin disease. It is characterized by immune cell activation and altered epidermal differentiation. S100A7 (psoriasin) is overexpressed in psoriasis, suggesting a determinant role of this protein in inflammation and keratinocyte differentiation.
    Objective: The purpose of this study was to investigate the expression of S100A7 in the skin from psoriatic patients undergoing biological therapy with adalimumab, etanercept or ustekinumab.
    Methods: S100A7 expression and distribution were analyzed by immunohistochemistry.
    Results: S100A7, overexpressed in epidermal keratinocytes of psoriatic lesions, was downregulated, under the biological therapy with adalimumab, etanercept or ustekinumab, only in patients achieving a PASI score<15.
    Conclusions: Dysregulation of S100A7 may represent a non-negligible player in the maintenance of psoriasis and the relative epidermal changes. Blockage of S100A7 may represent an additional therapeutic approach in the treatment of psoriasis.
    Mesh-Begriff(e) Adalimumab/pharmacology ; Adalimumab/therapeutic use ; Adult ; Aged ; Etanercept/pharmacology ; Etanercept/therapeutic use ; Female ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Psoriasis/drug therapy ; Psoriasis/metabolism ; S100 Calcium Binding Protein A7 ; S100 Proteins/metabolism ; Skin/drug effects ; Skin/metabolism ; Ustekinumab/pharmacology ; Ustekinumab/therapeutic use ; Young Adult
    Chemische Substanzen S100 Calcium Binding Protein A7 ; S100 Proteins ; S100A7 protein, human ; Ustekinumab (FU77B4U5Z0) ; Adalimumab (FYS6T7F842) ; Etanercept (OP401G7OJC)
    Sprache Englisch
    Erscheinungsdatum 2015-10
    Erscheinungsland Netherlands
    Dokumenttyp Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1024446-3
    ISSN 1873-569X ; 0923-1811
    ISSN (online) 1873-569X
    ISSN 0923-1811
    DOI 10.1016/j.jdermsci.2015.07.009
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus.

    D'Amico, Fabio / Skarmoutsou, Evangelia / Lo, Lauren J / Granata, Mariagrazia / Trovato, Chiara / Rossi, Giulio A / Bellocchi, Chiara / Marchini, Maurizio / Scorza, Raffaella / Mazzarino, Maria Clorinda / Keinan, Alon

    Immunology letters

    2017  Band 181, Seite(n) 58–62

    Abstract: Autoimmune diseases often share common susceptibility genes. Most genetic variants associated with susceptibility to systemic lupus erythematosus are also associated with other autoimmune diseases. The X-linked variant rs2294020 is positioned in exon 7 ... ...

    Abstract Autoimmune diseases often share common susceptibility genes. Most genetic variants associated with susceptibility to systemic lupus erythematosus are also associated with other autoimmune diseases. The X-linked variant rs2294020 is positioned in exon 7 of the CCDC22 gene. The encoded protein functions in the regulation of NF-κB, a master regulator in immune response. The aim of this study is to investigate whether the rs2294020 polymorphism may be a general susceptibility factor for autoimmunity. We evaluated case-control association between the occurrence of rs2294020 and different autoimmune diseases, including new data for systemic lupus erythematosus and previous genome-wide association studies (GWAS) (though most did not analyse the X chromosome) of psoriasis, celiac disease, Crohn's disease, ulcerative colitis, multiple sclerosis, vitiligo, type-1 diabetes, rheumatoid arthritis, and ankylosing spondylitis. Cases from patients affected by amyotrophic lateral sclerosis and type-2 diabetes were also included in the study. We detected nominal significant associations of rs2294020 with systemic lupus erythematosus (additive model test: p=0.01), vitiligo (p=0.016), psoriasis (p=0.038), and in only one of two studies of multiple sclerosis (p=0.03). Our results suggest that rs2294020 is associated with the risk of several autoimmune diseases in European populations, specifically with diseases that present themselves, among else, in the skin.
    Sprache Englisch
    Erscheinungsdatum 2017-01
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 445150-8
    ISSN 1879-0542 ; 0165-2478
    ISSN (online) 1879-0542
    ISSN 0165-2478
    DOI 10.1016/j.imlet.2016.11.011
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang